Retail newcomers could add to digital health adoption pressure in 2023

TEMPO and ACCESS are two new models that signal a large change in how the federal government intends to govern cost, quality and accountability in Medicare. Bill Charnetski, government affairs pro at PointClickCare, offers a deep dive.

Dr. Alex Pastuszak, cofounder and CEO of Paterna Biosciences, discusses the company’s recent announcement that it grew human sperm in a lab and used it to create embryos with the goal of impacting the future of male fertility treatment.

Before jumping into interventions, the first step is quantifying the risk that's impacting the population and driving costs, says Saleem Tahir, COO of MedeAnalytics.